Bruce L A Carter insider trades
Open-market stock purchases and sales by Bruce L A Carter, Director at Enanta Pharmaceuticals Inc, from SEC Form 4 filings since May 21, 2010.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Mar 11, 2026 | ENTA Enanta Pharmaceuticals Inc | Bought (not open market) | — |
Companies traded
- ENTA Enanta Pharmaceuticals Inc: 7 sales, last Mar 11, 2026
- MRTX Mirati Therapeutics, Inc: 25 sales, last Jan 23, 2024
- XNCR Xencor Inc: 8 sales, last Jun 14, 2017
- RGLS Regulus Therapeutics Inc: 1 sale, last Jun 10, 2015
- "RGLS" Regulus Therapeutics Inc: other filings, last May 22, 2014
- QLTI QLT Inc/bc: other filings, last May 26, 2011
- ZGEN Zymogenetics Inc: other filings, last Oct 8, 2010